Is it time to adopt proton pump inhibitors in the prevention of non-steroidal anti-inflammatory drug gastropathy?

Dig Liver Dis. 2000 Apr;32(3):209-10. doi: 10.1016/s1590-8658(00)80822-1.
No abstract available

Publication types

  • Review

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Benzimidazoles / therapeutic use
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Lansoprazole
  • Omeprazole / analogs & derivatives*
  • Omeprazole / therapeutic use
  • Pantoprazole
  • Proton Pump Inhibitors*
  • Stomach Diseases / chemically induced
  • Stomach Diseases / metabolism
  • Stomach Diseases / prevention & control*
  • Sulfoxides / therapeutic use

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzimidazoles
  • Enzyme Inhibitors
  • Proton Pump Inhibitors
  • Sulfoxides
  • Lansoprazole
  • Pantoprazole
  • Omeprazole